There has been wide variation in the reported haemorrhagic manifestati
ons of factor VII deficiency. We examined type and frequency of clinic
al manifestations in 28 Iranian and Italian patients with severe defic
iency (factor VII coagulant activity 2% or less). The most frequent sy
mptoms were epistaxis and menorrhagia, whereas soft tissue bleeding su
ch as haemarthrosis and muscle haematoma was less frequent. Only 5 of
9 patient who underwent surgery without factor VII replacement therapy
had postoperative bleeding severe enough to require blood transfusion
. No thrombotic manifestation occurred. A factor VII functional assay
based on the use of human thromboplastin was a better predictor of the
bleeding tendency of these patients than a rabbit thromboplastin-base
d functional assay or immunoassay. On the whole, this study shows that
in severe factor VII deficiency bleeding in mucosal tracts is not unc
ommon. Surgery can sometimes be performed without replacement therapy
and without haemorrhagic complications.